Cha Vaccine Institute is experiencing a sharp decline in early trading following news of a stake sale by CHA Biotech.


As of 9:15 a.m. on March 19, 2026, shares of Cha Vaccine Institute are trading at 2,650 won, down 495 won (15.74%) from the previous day.




On this day, Cha Vaccine Institute announced in a regulatory filing that its largest shareholder, CHA Biotech, has signed a share purchase agreement to transfer 8,948,813 shares to Sorux and Aribio Investment Purpose No. 13, among others. The total transaction amount is approximately 23.8 billion won. As a result of this sale, CHA Biotech's ownership stake in Cha Vaccine Institute will decrease to 4.99%.

[Market Focus] Cha Vaccine Institute Drops Over 15% on CHA Biotech Stake Sale View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing